September 18, 2007 — The US Food and Drug Administration (FDA) and Johnson & Johnson have informed healthcare professionals of a revision to the prescribing information for haloperidol, an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback